home All News open_in_new Full Article
United States FDA Approves NM8074 (Ruxoprubart) IND for Treating Dermatomyositis (DM): A Chronic Inflammatory Disorder of the Skin
today 5 h. ago attach_file Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Events
ID: 1600302590